# Sphere Medical Holding

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sphere-medical-holding

- Industry: Medical Devices & Equipment
- Headquarters: Cambridge, UK
- Website: www.spheremedical.com
- Total disclosed funding: $21M
- Latest round: Series C (Mar 31, 2010)
- Investors on record: 9

## About

Sphere Medical Holding Ltd. is a company engaged in developing advanced medical technologies that enhance patient care, particularly in critical environments such as intensive care units and surgical settings.Sphere Medical specializes in medical technology development with a focus on real-time patient monitoring solutions. Founded in Cambridge, UK, the company has undergone strategic pivots to enhance its product offerings. Sphere Medical secured GBP 13.2 mn in PIPE funding from Arthurian Life Sciences on April 22, 2015, raising a total of GBP 13.2 mn to date. The company has participated in 6 different funding deals since inception.Sphere Medical manufactures innovative monitoring solutions aimed at improving patient care in critical environments. Their flagship products deliver real-time physiological data, addressing challenges in vital sign accuracy and timely medical intervention. These solutions are utilized by healthcare facilities across North America and Europe, targeting medical professionals dedicated to high-quality patient care.In the most recent fiscal year, Sphere Medical reported revenue of GBP 3,866.60 mn, with an EBITDA of GBP -3,418,777.40 in 2018, reflecting their financial performance in the medical technology sector.Sphere Medical plans to leverage its recent GBP 13.2 mn investment to expand its product line with upcoming innovations in patient monitoring technology. The company aims to enter new markets in Europe and North America by 2023, focusing on enhancing its presence in regions with growing healthcare demands. The funding will support the development and marketing of these new products, aligning with their strategy to grow their market share and improve patient care outcomes.

## Funding rounds

- Series C, Mar 31, 2010, $9.4M — N47, Herald Investment Management, Edwards Lifesciences Corporation, Hotbed, Quest Management, Biovest, Artemis, Fritas A/S
- Series C, Oct 24, 2008, $2.7M — Quest Management
- Series C, Apr 4, 2008, $9.2M — Oxford Capital Partners, Herald Investment Management, Hotbed, Artemis, Fritas A/S

## Investors

- Oxford Capital Partners (https://capitalatlas.ai/funds/oxford-capital-partners) — Series C
- Herald Investment Management (https://capitalatlas.ai/funds/herald-investment-management) — Series C
- Hotbed — Series C
- Artemis (https://capitalatlas.ai/funds/artemis) — Series C
- Fritas A/S — Series C
- Quest Management (https://capitalatlas.ai/funds/quest-management) — Series C
- N47 (https://capitalatlas.ai/funds/n47) — Series C
- Edwards Lifesciences Corporation — Series C
- Biovest — Series C